Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-06-29 18:05:24 ET · period of report 2026-06-24 · accession 0001061983-26-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-06-29 18:05 | 2026-06-24 | CYTK | Lee Sung | EVP, CFO | M - OptEx | $47.10 | +38.7K | 102.0K | +61% | +$1.82M |
| DT | 2026-06-29 18:05 | 2026-06-24 | CYTK | Lee Sung | EVP, CFO | S - Sale+OE | $82.30 | -38.7K | 63.2K | -38% | -$3.19M |
| DMT | 2026-06-29 18:05 | 2026-06-24 | CYTK | Lee Sung | EVP, CFO | M - OptEx | $0.00 | -38.7K | 27.8K | -58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-24 | M | A | 23,370 | $48.51 | 86,591 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-24 | M | A | 9,307 | $44.36 | 95,898 | D | — | — | |
| 3 | Common | Common Stock | 2026-06-24 | M | A | 2,817 | $44.36 | 98,715 | D | — | — | |
| 4 | Common | Common Stock | 2026-06-24 | M | A | 1,113 | $48.51 | 99,828 | D | — | — | |
| 5 | Common | Common Stock | 2026-06-24 | M | A | 188 | $44.36 | 100,016 | D | — | — | |
| 6 | Common | Common Stock | 2026-06-24 | M | A | 822 | $44.36 | 100,838 | D | — | — | |
| 7 | Common | Common Stock | 2026-06-24 | M | A | 1,113 | $48.51 | 101,951 | D | — | — | |
| 8 | Common | Common Stock | 2026-06-24 | S | D | 38,730 | $82.30 | 63,221 | D | — | — | |
| 9 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-06-24 | M | D | 23,370 | $0.00 | 30,047 | D | $48.51 · 2025-06-02 to 2034-05-30 | 23,370 Common Stock | |
| 10 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-06-24 | M | D | 9,307 | $0.00 | 32,019 | D | $44.36 · 2025-04-14 to 2035-03-13 | 9,307 Common Stock | |
| 11 | Derivative | Incentive Stock Option (Right to Buy) | 2026-06-24 | M | D | 2,817 | $0.00 | 6,199 | D | $44.36 · 2025-04-14 to 2035-03-13 | 2,817 Common Stock | |
| 12 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-06-24 | M | D | 1,113 | $0.00 | 28,934 | D | $48.51 · 2025-06-02 to 2034-05-30 | 1,113 Common Stock | |
| 13 | Derivative | Incentive Stock Option (Right to Buy) | 2026-06-24 | M | D | 188 | $0.00 | 6,011 | D | $44.36 · 2025-04-14 to 2035-03-13 | 188 Common Stock | |
| 14 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-06-24 | M | D | 822 | $0.00 | 31,197 | D | $44.36 · 2025-04-14 to 2035-03-13 | 822 Common Stock | |
| 15 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-06-24 | M | D | 1,113 | $0.00 | 27,821 | D | $48.51 · 2025-06-02 to 2034-05-30 | 1,113 Common Stock |